Molybdenum disulfide | CAS:1317-33-5
Molybdenum disulfide
- 名称:二硫化钼 | Molybdenum disulfide
- CAS号:1317-33-5
- 别名:Molybdenum disulphide
- 分子式:MoS2
- 分子量:160.07
- EINESC号:215-263-9
产品描述
物理化学性质
没有数据 | 没有数据 |
---|
安全数据
安全说明书 | S22;S24/25 |
---|
产品合成路线
更多
名称 | CAS号 |
---|
更多
文章
同行评议文献
Synthesis and evaluation of heteroaryl-ketone derivatives as a novel class of VEGFR-2 inhibitors.Eugene L Piatnitski Chekler et al.Bioorganic & medicinal chemistry letters, 18(15), 4344-4347 (2008-07-22)
Discovery of a novel class of PPARdelta partial agonists.Barry G Shearer et al.Bioorganic & medicinal chemistry letters, 18(18), 5018-5022 (2008-08-30)
Meanwell, N., A.; et al. Bioorganic & Medicinal Chemistry Letters, 20, 1460-1460 (2010)
Engineering Styrene Monooxygenase for Biocatalysis: Reductase-Epoxidase Fusion Proteins.Thomas Heine et al.Applied biochemistry and biotechnology, 181(4), 1590-1610 (2016-11-11)
Indole ring oxidation by activated leukocytes prevents the production of hypochlorous acid.V F Ximenes et al.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas, 38(11), 1575-1583 (2005-11-01)
Synthesis of 3,3-diindolyl oxyindoles efficiently catalysed by FeCl3 and their in vitro evaluation for anticancer activity.Ahmed Kamal et al.Bioorganic & medicinal chemistry letters, 20(17), 5229-5231 (2010-08-03)
Fluorescence of protonated excited-state forms of 5-hydroxytryptamine (serotonin) and related indoles.R F Chen Proceedings of the National Academy of Sciences of the United States of America, 60(2), 598-605 (1968-06-01)
Tryptophan 2,3-dioxygenase (TDO) inhibitors. 3-(2-(pyridyl)ethenyl)indoles as potential anticancer immunomodulators.Eduard Dolusić et al.Journal of medicinal chemistry, 54(15), 5320-5334 (2011-07-06)
Identification of potent ITK inhibitors through focused compound library design including structural information.Matthias Herdemann et al.Bioorganic & medicinal chemistry letters, 20(23), 6998-7003 (2010-10-23)
Synthesis and evaluation of 3-aroylindoles as anticancer agents: metabolite approach.Yu-Shan Wu et al.Journal of medicinal chemistry, 52(15), 4941-4945 (2009-07-10)
备注
Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).
名称 | CAS号 |
---|
相关产品
相关资讯
问
热门标签
询 单
请 填 写 相 关 信 息
- 请填写产品名称!
- CAS号
- 请正确填写公司名称!
- 请正确填写联系人!
- 请正确填写联系电话!
- 请正确填写联系邮箱!
- 请描述您的问题!